Showing results (381-390 of 488) with videos related to

Sort By:
Pageof 49
The Journal of Rheumatology|May 17, 2019
Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT GroupFrancis Guillemin, Camille Ricatte, Annica Barcenilla-Wong, et al.
Rheumatology (Oxford, England)|August 25, 2014
Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapiesPhilip G Conaghan, Paul M Peloso, Sharlette V Everett, et al.
RMD Open|September 27, 2017
Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring systemMaria-Antonietta D'Agostino, Lene Terslev, Philippe Aegerter, et al.
Lancet (London, England)|July 3, 2015
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trialIain B McInnes, Philip J Mease, Bruce Kirkham, et al.
Rheumatology (Oxford, England)|September 18, 2016
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA studyLesley-Anne Bissell, Elizabeth M A Hensor, Lukasz Kozera, et al.
The Lancet. Rheumatology|January 27, 2024
MRI of the joint and evaluation of the granulocyte-macrophage colony-stimulating factor-CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic studyMark C Genovese, Mario Berkowitz, Philip G Conaghan, et al.
Pain|May 14, 2024
Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerationsDale J Langford, Remington P Mark, Fallon O France, et al.
Annals of the Rheumatic Diseases|March 23, 2016
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniquesPhilip G Conaghan, Mikkel Østergaard, Michael A Bowes, et al.
The Journal of Rheumatology|April 5, 2007
Summary findings of a systematic review of the ultrasound assessment of synovitisFredrick Joshua, Marissa Lassere, George A Bruyn, et al.
Rheumatology (Oxford, England)|June 11, 2026
T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practiceInnocent C Anioke, Fatih Tastekin, Gulay Alp, et al.
Pageof 49